Actas Dermosifiliogr. 2024 Feb 19:S0001-7310(24)00154-6. doi: 10.1016/j.ad.2024.02.013. Online ahead of print.
ABSTRACT
Several studies suggest that patients with psoriasis have a higher incidence of neoplasms or recurrence, especially of the skin, which could be associated with the use of therapies to treat psoriasis. Furthermore, the evidence available on the safety profile of some treatments in this context, and the management of these patients is scarce, which is why clinical practice guidelines with recommendations on the management of psoriasis in cancer patients are ambiguous. This study provides recommendations on the management and use of the therapies currently available for these patients. They are the result of a Delphi consensus reached by 45 dermatologists of the Spanish Academy of Dermatology and Venereology Psoriasis Working Group, whose goal is to help specialists in the field in their decision-making processes.
PMID:38382743 | DOI:10.1016/j.ad.2024.02.013